Hans-Joachim Lück

Hans-Joachim Lück

UNVERIFIED PROFILE

Are you Hans-Joachim Lück?   Register this Author

Register author
Hans-Joachim Lück

Hans-Joachim Lück

Publications by authors named "Hans-Joachim Lück"

Are you Hans-Joachim Lück?   Register this Author

7Publications

164Reads

21Profile Views

Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Lancet Oncol 2018 09 9;19(9):1247-1258. Epub 2018 Aug 9.

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health, Department of Gynecology with Center for Oncological Surgery, Berlin, Germany.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045183037
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(18)30372-3DOI Listing
September 2018

Response.

J Natl Cancer Inst 2014 Mar 28;106(3):djt452. Epub 2014 Feb 28.

Affiliations of authors: Department of Gynecology and Obstetrics, Klinikum Frankfurt Höchst, Frankfurt, Germany (VM); Department of Gynecology and Obstetrics, Klinikum Offenbach GmbH, Offenbach, Germany (CJ); National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany (AS); Department of Gynecology and Obstetrics, University of Duesseldorf, Duesseldorf, Germany (JH); Gynäkologisch-Onkologische Praxis Hannover, Hannover, Germany (H-JL); Department of Gynecology and Gynecologic Oncology, KEM Hussenstift, Essen, Germany (AdB); Department of Gynecology, University of Halle, Halle (Saale), Germany (CT); Medizinisches Zentrum Bonn-Friedensplatz, Bonn, Germany (CK); Department of Gynecology and Obstetrics, University of Bonn, Bonn, Germany (WK); Ev. Krankenhaus Bethesda, Brustzentrum Niederrhein, Mönchengladbach, Germany (UAN); Department of Gynecology and Obstetrics, University of Jena, Jena, Germany (IBR); WiSP Research Institute, Langenfeld, Germany (AH); Department of Gynecology and Obstetrics, University of Ulm, Ulm, Germany (RK); Department of Gynecology and Obstetrics, Helios Klinikum Berlin-Buch, Berlin, Germany (MU).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt452DOI Listing
March 2014

Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases.

Eur J Cancer 2009 Nov 28;45(16):2792-8. Epub 2009 Jul 28.

Department of Gynaecology and Gynaecological Oncology, EUSOMA-Breast Unit, HSK, Dr. Horst-Schmidt Klinik, Ludwig-Erhard Str.100, Wiesbaden D-65199, Germany.

View Article

Download full-text PDF

Source
http://ac.els-cdn.com/S0959804909005103/1-s2.0-S095980490900
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S095980490900510
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2009.06.027DOI Listing
November 2009